Skip to content

Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia

Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia: a Randomized Multicenter Controlled Trial (ACC Baxter)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02322502
Enrollment
352
Registered
2014-12-23
Start date
2015-02-28
Completion date
2016-02-29
Last updated
2016-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia With Use of LMA (Laryngeal Mask Airway)

Keywords

laryngeal mask airway, desflurane, sevoflurane, propofol

Brief summary

The aim of this study is first to assess if desflurane is superior in order to achieve a faster emergence from anesthesia.

Detailed description

The aim of this study is first to assess if desflurane is superior in order to achieve a faster emergence from anesthesia (stating the date of birth) and second if desflurane is non-inferior in the occurrence of airway complications compared to sevoflurane or total intravenous anesthesia with propofol in the setting of laryngeal mask airway.

Interventions

DRUGDesflurane

inhalation with laryngeal mask to maintain anaesthesia

DRUGSevoflurane

inhalation with laryngeal mask to maintain anaesthesia

DRUGpropofol

intravenous injection to maintain anaesthesia

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Planned anesthesia with use of LMA (laryngeal mask airway) * Planned duration of anesthesia between 0.5 and 2 hours * Age between 18-75 years * Both gender * Body mass index (BMI) \<35 * ASA 1-3 * Written informed consent prior to study participation

Exclusion criteria

* Planned additional regional and local anesthesia * Contra-indication for the use of a laryngeal mask airway * Asthma * COPD IV * Known allergy or hypersensitivity to any drugs administered during this study * Women who are pregnant, breast-feeding or women of childbearing potential not using adequate contraceptive methods * Participation in a drug or device trial within the previous 30 days. * Patients legally unable to give written informed consent. * Patients with severe psychiatric disorders * Recent (\<6 months) history of alcohol or drug abuse * Patients with severe neuropsychiatric disorders * Non-fluency in German language

Design outcomes

Primary

MeasureTime frameDescription
time of emergence from anesthesiaup to 15 minutestime of emergence from anesthesia defined as time between cessation of anesthesia until patient is able to state his/her date of birth on command

Secondary

MeasureTime frameDescription
Airway reactions (Incidence of intraoperative coughs, laryngospasm)up to 2 hoursIncidence of intraoperative coughs (induction/maintenance) - non-inferiority design Incidence of intraoperative laryngospasm (induction/maintenance) Incidence of cough at emergence Incidence of laryngospasms at emergence
Emergence timesup to 15 minutesTime to remove laryngeal mask Time to open eyes on command Time to respond on command (press hand) Time to state the name on command Recovery Index (RI = 1 + Aldrete5min/\[(2xextubation time) + 1 x opening eyes time)\]

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 16, 2026